Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START: Early Deferiprone in Children with Beta Thalassemia
NCT03591575Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of deferiprone in iron overload, sponsored by Chiesi Farmaceutici S.p.A.. Started Nov 2018; status: completed.
02
Drugs
deferiprone
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT03591575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591575.